Literature DB >> 18556211

Genetic absence epilepsy rats from Strasbourg have increased corticothalamic expression of stargazin.

K L Powell1, M Kyi, C A Reid, L Paradiso, G M D'Abaco, A H Kaye, S J Foote, T J O'Brien.   

Abstract

Stargazin is membrane bound protein involved in trafficking, synapse anchoring and biophysical modulation of AMPA receptors. A quantitative trait locus in chromosome 7 containing the stargazin gene has been identified as controlling the frequency and duration of absence seizures in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS). Furthermore, mutations in this gene result in the Stargazer mouse that displays an absence epilepsy phenotype. GAERS stargazin mRNA expression is increased 1.8 fold in the somatosensory cortex and by 1.3 fold in the thalamus. The changes were present before and after the onset of absence seizures indicating that increases are not a secondary consequence of the seizures. Stargazin protein expression was also significantly increased in the somatosensory cortex after the onset of spontaneous seizures. The results are of significant importance beyond the GAERS model, as they are the first to show that an increase in stargazin expression may be pro-epileptic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556211     DOI: 10.1016/j.nbd.2008.04.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  6 in total

1.  mRNA blood expression patterns in new-onset idiopathic pediatric epilepsy.

Authors:  Hansel M Greiner; Paul S Horn; Katherine Holland; James Collins; Andrew D Hershey; Tracy A Glauser
Journal:  Epilepsia       Date:  2012-11-21       Impact factor: 5.864

Review 2.  Low threshold T-type calcium channels as targets for novel epilepsy treatments.

Authors:  Kim L Powell; Stuart M Cain; Terrance P Snutch; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 3.  Sex differences in the neurobiology of epilepsy: a preclinical perspective.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Neurobiol Dis       Date:  2014-07-21       Impact factor: 5.996

4.  Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.

Authors:  Gabi Dezsi; Ezgi Ozturk; Davor Stanic; Kim L Powell; Hal Blumenfeld; Terence J O'Brien; Nigel C Jones
Journal:  Epilepsia       Date:  2013-03-06       Impact factor: 5.864

5.  Glutamate Signaling Pathway in Absence Epilepsy: Possible Role of Ionotropic AMPA Glutamate Receptor Type 1 Subunit.

Authors:  Fahime Zavvari; Sayed Mostafa Modarres Mousavi; Maryam Ejlali; Shahram Barfi; Fariba Karimzadeh
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

6.  Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.

Authors:  Johanna Elms; Kim L Powell; Leena van Raay; Stefanie Dedeurwaerdere; Terence J O'Brien; Margaret J Morris
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.